Tryp Therapeutics Stock (OTC:TRYPF), Quotes and News Summary

Q: What sector and industry does Tryp Therapeutics (TRYPF) operate in?

Tryp Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.

Tryp Therapeutics Stock (OTC: TRYPF) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 43.819K
Day Range	- - -
52 Wk Range	0.004 - 0.092
Market Cap	$3.471M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More

Psychedelics Developer Secures $100M In Series A Funding, Will Support MDMA Approval To Treat PTSD

Lara Goldstein

Tryp Therapeutics Explores Psilocybin's Potential In New Trials To Treat IBS And Fibromyalgia

Psychedelics biotech Tryp Therapeutics (OTCQB: TRYPF) is advancing its psilocybin-based portfolio through several recent milestones.

Lara Goldstein

Psyched: NDAA Amendments Blocked, National Practitioners Network, Marijuana In Jackie Kennedy's Garden And More

GOP-Controlled House Committee Blocks All Cannabis & Psychedelics Amendments To Defense Bill: Now, No Floor Vote

Lara Goldstein

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About

Sector

Healthcare

Industry

N/A

Tryp Therapeutics Inc is a clinical-stage biotechnology company focused on developing psilocybin-rel...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tryp Therapeutics (TRYPF) stock?

You can purchase shares of Tryp Therapeutics (OTCQB: TRYPF) through any online brokerage.

View our list of the best stock brokerages.

Who are Tryp Therapeutics's (TRYPF) competitors?

There are no as such competitors for Tryp Therapeutics.

What is the target price for Tryp Therapeutics (TRYPF) stock?

The latest price target for Tryp Therapeutics (OTCQB: TRYPF) was reported by Ladenburg Thalmann on Thursday, January 5, 2023. The analyst firm set a price target for 1.50 expecting TRYPF to rise to within 12 months (a possible 4066.67% upside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Tryp Therapeutics (TRYPF)?

The stock price for Tryp Therapeutics (OTCQB: TRYPF) is $0.036 last updated April 18, 2024 at 11:59 AM EDT.

Does Tryp Therapeutics (TRYPF) pay a dividend?

There are no upcoming dividends for Tryp Therapeutics.

When is Tryp Therapeutics (OTCQB:TRYPF) reporting earnings?

Tryp Therapeutics does not have any upcoming earnings scheduled.

Is Tryp Therapeutics (TRYPF) going to split?

There is no upcoming split for Tryp Therapeutics.

What sector and industry does Tryp Therapeutics (TRYPF) operate in?

Tryp Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the OTCQB.